Derive New Insights and Transform How Cancer Care Is Delivered Worldwide
Make remarkable advances in oncology treatments including immuno-oncology, combination therapies and launch in multiple indications utilizing our data, advanced technologies and expert services. Our solutions help clients with:
- More targeted R&D including faster, more efficient clinical development and better understanding of unmet needs
- Better demonstration of value by quantifying cost of care and the impact of new treatments
- New ways of bringing the right messages and information to clinicians and patients
- Enriched information sources to understand patients, including biomarker data and treatment dynamics
Accelerate Research Efforts and Dramatically Improve Cancer Treatments
Develop and deliver truly innovative cancer treatments by accessing our ever-expanding sources of anonymous patient-level data across geographies.
Leverage cloud-based technology and advanced analytics to extract, analyze and visualize data quickly and effectively.
Increase your organization’s performance by tapping into uniquely rich insights that support all functions, including R&D, HEOR/drug safety and commercial teams.
- Determine patient segmentation and targeting based on biomarkers and actual clinical practice
- Size the market accurately to assess brand potential for all tumors across multiple indications
- Monitor brand performance, new product uptake, launch and therapy adoption globally
- Evaluate and refine promotional resource allocation
- Benchmark against competitor performance
- Optimize oncology products across the lifecycle
- Gain faster market access for your products
Gain a Holistic View of the Patient that No Single Data Source Can Provide
Multiple data sources provide a single, comprehensive view:
- Near-census treatment insights
- Dynamic representation of total patient care
- Disparate data sources
- Privacy protection encryption
Get an Unparalleled View of the Cancer Patient’s Diagnosis and Treatment Journey
Create Your Own Oncology RWE Ecosystem
We have access to more than 370 oncology-specific publications and market access, evidence development and submission support in 20+ countries.
Rich oncology information
Multi sourced oncology RWD covering:
- 13+ countries
- 3 continents
- 25+ primary cancers
- Access to cancer-specific registries
- Integrated data solutions, e.g., breast, NSC lung cancer
- Largest, most comprehensive oncology platform commercially available in the U.S.
- EMR extraction capabilities in Europe
- HEOR and pharmaco-epidemiology studies
- Leading oncology health economic model for rigorous and efficient tumor modeling
- Global dedicated team, including tumor-specific specialists
Increase Depth of Insights for Biomarker and Genomic Subpopulations
IMS Health works in partnership with Foundation Medicine® to increase depth of insights for biomarker and genomic subpopulations. We provide multiple Real-World Data (RWD) sources relevant for oncology, including:
- Claims (medical and pharmacy)
- Patient demographics
- Cost utilization
- Electronic Medical Records (EMR)
- Clinical attributes such as tumor type, stage, histology/morphology
FoundationCORETM comprehensive genomic knowledge base provides:
- Tumor mutation & biomarker status for 300+ genes in solid tumors, 415+ genes in hematological malignancies
- At the biomarker level (e.g., EGFR)
- At the genomic alteration level (e.g., EGFR T790M mutation)
Richer Oncology Insights with Pygargus
With increased demand for outcomes data to guide clinical practice, data extraction from EMRs is still a widely unexploited resource for epidemiological and clinical research based on unselected Real-World Data.
With our unique software Pygargus CXP, we can identify, extract and analyze large amounts of longitudinal data from electronic medical records and support our customers with well-performed analyses of the Real-World Data we capture.
- Extract EMR data—Identify, extract and structure large amounts of longitudinal data from EMRs in Scandinavia
- Customize and Link—Link data to various registers at the patient level:
- Breast Cancer Registry
- Melanoma Cancer Registry
- Ovarian Cancer Registry
- Leukemia Registry
- Prostate Cancer Registry
- Scientific rigor and academic partnerships—Combine advanced analytical capabilities in partnership with external key opinion leaders and academic groups
Interested in learning more about how IMS Health's specialty/oncology solutions can help you succeed? Let us know how we can help you:
Thank you for your interest. A representative will be in touch with you shortly.